As other players have moved out of the vaccines business, it has become more interesting for others to go in. The manufacturers that are left gain a lot of pricing power, and interest has also risen in the face of pandemic risks. |
European pharmaceuticals have outperformed quite considerably over the last year or so. Fundamentally, they should continue doing better in 2006. |
I don't think people have really modeled in the generics acquisitions yet. The generics acquisition isn't something that has been seen positively yet. |
I don't think people have really modeled in the generics acquisitions yet. The generics acquisition isn't something that has been seen positively yet. The shares have performed a bit better since the research and development day. |
Their products are quite unique. The figures were strong. |